Thomas J. Herzfeld Advisors’s Idexx Laboratories IDXX Stock Holding History

Thomas J. Herzfeld Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6	Closed	-$2.62K	–	236
2023 Q3	$2.62K	Sell	6 -1	-14%	-$499	﹤0.01%	302
2023 Q2	$3.39K	Sell	7 -2	-22%	-$958	﹤0.01%	296
2023 Q1	$4.5K	Hold	9	–	–	﹤0.01%	246
2022 Q4	$3.67K	Hold	9	–	–	﹤0.01%	265
2022 Q3	$3K	Hold	9	–	–	﹤0.01%	250
2022 Q2	$3K	Hold	9	–	–	﹤0.01%	254
2022 Q1	$5K	Hold	9	–	–	﹤0.01%	237
2021 Q4	$6K	Hold	9	–	–	﹤0.01%	251
2021 Q3	$6K	Buy	9 +1	+13%	+$672	﹤0.01%	240
2021 Q2	$5K	Buy	8 +2	+33%	+$1.1K	﹤0.01%	263
2021 Q1	$3K	Hold	6	–	–	﹤0.01%	300
2020 Q4	$3K	Hold	6	–	–	﹤0.01%	263
2020 Q3	$3K	Buy	+6	New	+$2.22K	﹤0.01%	214

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Thomas J. Herzfeld Advisors's IDXX Position: Q4 2023 in Review

Thomas J. Herzfeld Advisors sold out of Idexx Laboratories (IDXX) in Q4 2023, closing a stake of 6 shares — an estimated $2.62K sold.

Thomas J. Herzfeld Advisors first reported a position in IDXX in Q3 2020 and held it in 13 quarters. The position peaked at $6K in Q4 2021. 1,154 funds tracked by Wall St. Rank hold IDXX as of Q4 2023.

Thomas J. Herzfeld Advisors reported no remaining Idexx Laboratories position as of Q4 2023 after selling out during the quarter.
Thomas J. Herzfeld Advisors sold 6 Idexx Laboratories shares in Q4 2023, an estimated $2.62K.
Thomas J. Herzfeld Advisors first reported a position in Idexx Laboratories in Q3 2020 and held it in 13 quarters.
Thomas J. Herzfeld Advisors's Idexx Laboratories position peaked at $6K in Q4 2021.
1,154 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2023.

Based on Thomas J. Herzfeld Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.